Benlysta 200 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FJW23
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,153
Award facts
- Contract value 100% obligated
- $6,152.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $6,152.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Benlysta 200 mg/ml syringes. This non-set-aside contract will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 1, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive $999.9 billion pharmaceutical supply agreement valued through December 2026 that enables the contractor to deliver a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency. The company's federal contracting activity demonstrates significant capability in supplying specialty medications, vaccines, and medical devices across multiple therapeutic domains to support military and veteran healthcare systems. This particular delivery order for Benlysta, a biologic treatment for lupus, reflects the contractor's ongoing role in providing specialized pharmaceutical products to the Defense Health Agency and other federal healthcare customers through the DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FJW23?
SPE2DB25FJW23 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FJW23 worth?
The government has obligated $6,153 on SPE2DB25FJW23.
Is contract SPE2DB25FJW23 an order under another contract?
Yes. SPE2DB25FJW23 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJW23 competed?
The extent of competition for SPE2DB25FJW23 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award